1Mitwally MF, Bhakoo HS, Crickard K. Estradiol production during controlled ovarian hyperstimulation correlates with treatment outcome in women undergoing in vitro fertilization - embryo transfer[ J]. Fertil Steril,2006,86:588 - 596.
2Erdal Aktan, Kaan Bozkurt, Dilek Ozer, et al. The effect of mid - luteal estradiol level on the outcome of ICSI - ET cycles[ J]. Archives of Gynecology and Obstetrics,2004,269 (2), 134 - 138.
3Vicdan K, Zeki Isik A. Luteal phase hormonal profile in prediction of pregnancy outcome after assisted reproduction [J]. Eur J Obstet Gynecol Reprod Biol,2001,96( 1 ) : 98 -101.
4Friedler S,Zimerm A, Schachter M, et al. The midluteal decline in serum estradiol levels is drastic but not deleterious for implantation after in vitro fertilization and embryo transfer in patients with normal or high responses [J]. Fertil Steril,2005,83( 1 ) : 54 -60.
5Kolibianakis EM, Albano CA, Kahn J, et al. Exposure to high levels of luteinizing hormone and estradiol in the early follicular phase of gonadotropin - releasing hormone antagonist cycles is associated with a reduced chance of pregnancy [ J ]. Fertil Steril, 2003,79 ( 4 ) : 873 - 880.
6Ma WG, Song H, Das SK, et al. Estrogen is a critical determinant that specifies the duration of the window of uterine receptivity for implantation [ J ]. Nat Acad Sci,2003,100 (5) : 2963 - 2968.
7Sharara FI, MeClamrock HD. Ratio of estradiol concentration on the day of human chorionic gonadotrophin administration to mid - luteal estradiol concentration is predictive of in -vitro fertilization [ J ]. Hum Reprod, 1999,14( 11 ) :2777 -2782.
8Ozcakir HT, Levi R, Tavmergen E, et al. Premature luteinization defined as progesterone cstradiol ratio > 1 on HCG administration day seems to adversely affect clinical outcome in long gonadotrop in2releasing hormone agonist cycles [ J]. J Obstet Gynaecol Res, 2004,30 (2) : 1002 -1041.
9Hung Yu Ng E, Shu Biu Yeung W, Yee Lan Lau E, et al. A rapid decline in serum oestradiol concentrations around the midluteal phase had no adverse effect on outcome in 763 assisted reproduction cycles [J]. Hum Reprod,2000,15 (9) :1903 - 1908.
10Yu Ng EH, Yeung WS, Yee Lan Lau E, et al. High serum estradiol concentrations in fresh IVF cycles do not impair implantation and pregnancy rates in subsequent frozen -thawed embryo transfer cycles [J]. Hum Reprod,2000,15 (2) :250 -5.
3Mitchell MH,Swanson RJ,Oehninger S.In vivo effect of leukemia inhibitory factor (LIF) and an anti-LIF polyclonal antibody on murine embryo and fetal development following exposure at the time of transcervical blastocyst transfer[J].Biol Reprod,2002,67(2):460-464.
4Budwit-Novotny DA,Mccarty KS,Cox EB,et al.Immunohistochemical analyses of oestrogen receptor in endometrial carcinoma using a monoclonal antibody[J].Cancer Res,1986,46(10):5419-5425.
5Ziegler D,Fanchin R,Moustier B,et al.The hormonal control of endometrial receptivity:estrogen (E2) and progesterone[J].J Reprod Immunol,1998,39 (1-2):149-166.
6Ben-Nun I,Ghetle Y,Jaffe R,et al.Effect of preovulatory progesterone administration on the endometrial maturation and implantation rate after in vitro fertilization and embryo transfer[J].Fertil Steril,1990,53(2):276-283.
7Stewart CL,Kaspar P,Brunt LJ,et al.Blastocyst implantation depends on maternal expression of leukemia inhibitory factor[J].Nature,1992,359(6390):76-79.
8Tsai HD,Chang CC,Hsieh YY,et al.Leukemia inhibitory factor concentration in different endometrial locations between fertile and infertile women throughout different menstrual phases[J].J Assist Reprod Genet,2000,17(8):415-418.
9Cheng JG,Rodriguez CI,Stewart CL.Control of uterine receptivity and embryo implantation by steroid hormone regulation of LIF production and LIF receptor activity:towards a molecular understanding of "the window of implantation"[J].Rev Endocr Metab Disord,2002,3(2):119-126.
10Laird SM,Tucker man EM,Dalton CF,et al.The production of leukaemia inhibitory factor by human endometrium:presence in uterine flushings and production by cells in culture[J].Hum Reprod,1997,12(3):569-574.
2Unfer V,Casini ML,Gerli S,et al. Phytoestrogens may improvethe pregnancy rate in in vitro fertilization-embryo transfer cycles: a prospective, controlled, randomized trial [J]. Fertil Steril, 2004,82(6) : 1509-1513.
3Hung Yu,Ng E,Shu Biu Yeung W,et al. A rapid decline in serum oestradiol concentrations around the midluteal phase had no adverse effect on outcome in 763 assisted reproduction cycles [J]. Hum Reprod,2000,15(9) : 1903-1908.
4Baird DD,Wilcox AJ,Weinberg CR,et al. Preimplantation hor- monal differences between the conception and non-conception menstrual cycles of 32 normal women[J]. Hum Reprod, 1997,12 (12) :2607-2613.
5Sharara FI, McClamrock HD. Ratio of oestradiol concentration on the day of human chorionic gonadotrophin administration to mid- luteal oestradiol concentration is predictive of in vitro fertilization outcome [J].Hum Reprod, 1999,14( 11 ) :2777-2782.
6Vicdan K,Zeki-Isik A. Luteal phase hormonal profile in predic- tion of pregnancy outcome after assisted reproduction[J]. Eur J Obstet Gynecol Reprod Biol, 2001,96( 1 ) : 98-101.
7Friedler S,Zimerm A,Schachter M,et al. The midluteal decline in serumestradiol levels is drastic but not deleterious for implan- tation after in vitro fertilization and embryo transfer in patients with normal or high responses [ J ]. Fertil Steril, 2005,83 ( 1 ) : 54- 60.
8Farhi J, Weissman A, Steinfeld Z, et al. Estradiol supplementation during the luteal phase may improve the pregnancy in patients undergoing in vitro fertilization-embryo transfer cycles [J]. Fertil Steril, 2000,73 (4) : 761-766.
9Jung H,Roh HK. The effects of E2 supplementation from the early proliferative phase to the late secretory phase of the en- dometrium in HMG-stimulated IVF-ET [J]. J Assist Reprod Genet,2000,17 ( 1 ) :28-33.
